Caricamento...
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
Non-alcoholic steatohepatitis (NASH) is becoming a leading cause of cirrhosis with the burden of NASH-related complications projected to increase massively over the coming years. Several molecules with different mechanisms of action are currently in development to treat NASH, although reported effic...
Salvato in:
| Pubblicato in: | Gut |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMJ Publishing Group
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497577/ https://ncbi.nlm.nih.gov/pubmed/32381514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319104 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|